References
- Adams M, Gmünder F, Hamburger M (2007): Plants traditionally used in age related brain disorders – A survey of ethnobotanical literature. J Ethnopharmacol 113: 363–381.
- Bejar C, Wang R, Weinstock M (1999): Effect of rivastigmine on scopolamine-induced memory impairment in rats. Eur J Pharmacol 383: 231–240.
- Chattipakorn S, Pongpanparadorn A, Pratchayasakul W, Pongchaidacha A, Ingkaninan K, Chattipakorn N (2007): Tabernaemontana divaricata extract inhibits neuronal acetylcholinesterase activity in rats. J Ethnopharmacol 110: 61–68.
- Davies P, Maloney AJF (1976): Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet 2: 1403.
- de Angelis L, Furlan C (1995): The effects of ascorbic acid and oxiracetam on scopolamine- induced amnesia in a habituation test in aged mice. Behav Brain Res 64: 119–124.
- Dong WX, Ruan KF, Gu FH, Shen PN, Li PY, Lin ZH (2006): FBD used to improve learning and memory function of animals. Zhong Cao Yao 37: 1831–1835.
- Farlow M, Gracon SI, Hershey LA, Lewis KW, Sadowsky CH, Dolan-Ureno J (1992): A controlled trial of tacrine in Alzheimer’s disease The Tacrine Study Group. JAMA 268: 2523–2529.
- Hatip-Al-Khatib I, Egashira N, Mishima K, Iwasaki K, Iwasaki K., Kurauchi K, Inui K, Ikeda T, Fujiwara M (2004): Determination of the effectiveness of components of the herbal medicine Toki- Shakuyaku-San and fractions of Angelica acutiloba in improving the scopolamine-induced impairment of rat’s spatial cognition in eight-armed radial maze test. J Pharmacol Sci 96: 33–41.
- Howes MJ, Houghton PJ (2003): Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol Biochem Behav 75: 513–527.
- Hsieh MT, Lin YT, Lin YH, Wu CR (2000): Radix Angelica Sinensis extracts ameliorate scopolamine- and cycloheximide-induced amnesia but not p-chloroamphetamine-induced amnesia in rats. Am J Chin Med 28: 263–272.
- Iwasaki K, Satoh-Nakagawa T, Maruyama M, Monma Y, Nemoto M, Tomita N, Tanji H, Fujiwara H, Seki T, Fujii M, Arai H, Sasaki H (2005): A randomized observer-blind controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J Clin Psychiatry 66(2): 248–252.
- Kim DH, Kim DY, Kim YC, Jung JW, Lee S, Yoon BH, Cheong JH, Kim YS, Kang SS, Ko KH, Ryu JH (2007): Odakenin, a coumarin compound ameliorates scopolamine-induced memory disruption in mice. Life Sci 80: 1944–1950.
- Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SL (1994): A 30-week randomized controlled trial of highdose tacrine in patients with Alzheimer’s disease. JAMA 271: 985–991.
- Kopelman MD, Corn TH (1988): Cholinergic blockade as a model of cholinergic depletion. Brain 111: 1079–1110.
- Kuang X, Du JR, Liu YX, Zhang GY, Peng HY (2008): Postischemic administration of Z-Ligustilide ameliorates cognitive dysfunction and brain damage induced by permanent forebrain ischemia in rats. Pharmacol Biochem Behav 88: 213–221.
- Lahiri DK, Farlow MR, Greig NH, Sambamurti K (2002): Current drug targets for Alzheimer’s disease treatment. Drug Dev Res 56: 267–281.
- Leonard BE (2004): Pharmacotherapy in the treatment of Alzheimer’s disease: An update. World Psychiatry 3(2): 84–88.
- Lin ZH, Zhu DN, Yan YQ, Yu BY (2002): Study II on substance basis and mechanism of action of Danggui Shaoyao San in the prevention and treatment of senile dementia-similar efficacy in the prescription. Chin J Exp Traditional Med Formula 8(4): 19–21.
- Lin ZH, Zhu DN, Yan YQ, Yu BY, Wang QJ (2005): Protective effects of FBD-an experimental Chinese traditional medicinal formula on memory dysfunction in mice induced by cerebral ischemia-reperfusion. J Ethnopharmacol 97: 477–483.
- Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951): Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275.
- Lu MC (2001): Danggui Shaoyao San improve colchichine-induced learning acquisition impairment in rats. Acta Pharmacol Sin 22: 1149–1153.
- Oh MH, Houghton PJ, Whang WK, Cho JH (2004): Screening of Korean herbal medicines used to improve cognitive function for anti-cholinesterase activity. Phytomedicine 11: 544–548.
- Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT (1998): A 24-week double-blind placebo-controlled trial of donepezil in patients with Alzheimer’s disease. Neurology 50: 136–145.
- Rubio J, Dang H, Gong M, Liu X, Chen S, Gonzales GF (2007): Aqueous and hydroalcoholic extracts of Black Maca (Lepidium meyenii) improve scopolamine-induced memory impairment in mice. Food Chem Toxicol 45: 1882–1890.
- Shinno H, Utani E, Okazaki S, Kawamukai T, Yasuda H, Inagaki T, Inami Y, Horiguchi J (2007): Successful treatment with Yi-Gan San for psychosis and sleep disturbance in a patient with dementia with Lewy bodies. Prog Neuropsychopharmacol Biol Psychiatry 31: 1543–1545.
- Smriga M, Saito H, Nishiyama N (1995): Hoelen (Poria cocos Wolf) and ginseng (Panax Ginseng C A Meyer) the ingredients of a Chinese prescription DX-9386 individually promote hippocampal long-term potentiation in vivo. Biol Pharm Bull 18: 518–522.
- Toriizuka K, Hou PH, Yabe T, Iijima K, Hanawa T, Cyong JC (2000): Effects of Kampo medicine Toki- shakuyaku-san (Tang-Kuei- Shao-Yao-San) on choline acetyltransferase activity and norepinephrine contents in brain regions and mitogenic activity of splenic lymphocytes in ovariectomized mice. J Ethnopharmacol 71: 133–143.
- Zhang D, Liu GT, Shi JG, Zhang JJ (2006): Coeloglossum viride var bracteatum extract attenuates d-galactose and NaNO2 induced memory impairment in mice. J Ethnopharmacol 104: 250–256.
- Zhu W, Hu H (2007): A survey of TCM treatment for Alzheimer’s disease. J Tradit Chin Med 27: 226–232.